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Despite strides in combatting HIV worldwide, South Africa (SA) has 
the largest number of new HIV infections in the world, with about 
1 000 new infections occurring each day among adults aged 15 - 49 
years in 2012.[1] Early detection and effective HIV treatment extends 
life expectancy, improves life quality, and reduces HIV transmission, 
making it a cost-effective public health intervention.[2] The National 
Strategic Plan on HIV, sexually transmitted infections (STIs) and 
tuberculosis (TB) 2012 - 2016 aims to reduce new infections by at least 
50%.[3] However, the prevalence of infections across provinces ranges 
from 5% to over 14% in KwaZulu-Natal and the Eastern Cape.[4] 
HIV prevalence is highest in males aged between 15 and 49 years 
who engage in high-risk behaviours (in the order of 30%).[4] This 
same population is also at a higher risk of acute illness and injury and 
therefore more likely to present to the emergency department (ED) 
for care. In SA emergency care is a basic human right enshrined in 
the constitution.[5] EDs provide unprohibited access to care, to large 
volumes of patients for a short period of time. The ED population 
tends to be younger and is less likely to access primary healthcare 
(where most screening occurs). However, EDs remain underdeveloped 
in the healthcare system and play no role in the HIV epidemic. High 
rates of unrecognised HIV infection persist in the ED and therefore 
provide an opportunity for testing and linkage to care.[6] 
Despite many longitudinal programmes related to highly active 
antiretroviral therapy (HAART) and linkage to care in SA, the HIV epi-
de mic falls far short of The Joint United Nations Programme on HIV 
and AIDS (UNAIDS) ‘90-90-90’ target for HIV-infected individuals, (i.e. 
by 2020 90% of all people living with HIV will know their HIV status, 
90% will receive sustained antiretroviral therapy and 90% will achieve 
viral suppression). About 36% of patients admitted to EDs have 
undiagnosed HIV infection; EDs may therefore be a unique avenue to 
develop and implement an HIV testing strategy.[7]
In 2006 the US Centers for Disease Control (CDC) issued a new 
directive[8] for the opt-out approach to the routine testing of HIV 
in any population in the ED whereby opt out-testing would be: 
routine for all patients aged 13 to 64 years unless the prevalence of 
undiag nosed HIV infection in the patient population is documented 
to be <0.1%, and applied to all patients initiating treatment for TB 
and patients seeking treatment for sexually transmitted diseases, 
irrespective if known or suspected to have specific behavioural 
risks for HIV infection. Testing should be an opt-out approach 
(patients are informed that testing is going to be done unless they 
decline); screening should be incorporated into the general consent 
for medical care; and separate written consent and prevention 
counselling should not be required with HIV diagnostic testing or as 
part of HIV screening programmes in healthcare settings. Reasons for 
the opt-out approach include: by integrating opt-out screening into 
general consent, the screening process is streamlined and routinised; 
and patients may perceive this as being less stigmatising because 
they are not singled out for testing.
Studies examining the implementation, effectiveness, patient 
satisfaction and overall acceptability of the opt-out concept, have 
since been published. Such opt-out testing is not restricted to the 
USA and other high-income countries (HICs), but given similar 
recommendation from the World Health Organization (WHO). In 2007 
it was expanded to several low- and low-middle-income countries 
(LMICs).[9,10] 
This open-access article is distributed under 
Creative Commons licence CC-BY-NC 4.0.
HIV, trauma and the emergency departments: The CDC  
opt-out approach should be adopted in South Africa
TC Hardcastle,1 MB ChB, M Med (Chir), FCS (SA), PhD; B Hansoti,2 MB ChB, BSc (Hons), MPH, FACEP
1 Department of Surgery, University of KwaZulu-Natal, Durban, South Africa 
2 Department of Emergency Medicine, Johns Hopkins University, Baltimore, USA
Corresponding author: TC Hardcastle (timothyhar@ialch.co.za)
Background. Trauma is the fourth burden of disease in South Africa (SA). The risk group is the same as that for HIV/AIDS. The Centers for 
Disease Control and the World Health Organization promulgated the opt-out testing system 10 years ago and several high- and lower-middle-
income countries have adopted this approach. 
Objective. To review the feasibility of implementing the opt-out system in SA emergency departments. 
Methods. We examined the clinical, economic, practical and patient/provider perceptions concerning the scientific and ethical aspects of the 
opt-out concept.
Results. Patients were generally positive about the opt-out system and the overall test rate and disease identification rates were better than 
with other systems. Although initial costs may increase, the long-term cost benefit and prevention of transmission, due to linking to care, 
make this option attractive. 
Conclusion. The opt-out option for patients presenting to emergency departments with an acute life-threatening illness or trauma, and for 
those in critically ill states in an intensive care unit, is justifiable based on international and regional practices. This also has the potential to 
advance early highly active antiretroviral therapy and reduce treatment costs and the disease-adjusted life years for HIV management and 
trauma critical care. SA should adopt an opt-out testing system instead of the current tedious opt-in system.
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Methods
A literature review was performed using Medline and Google Scholar 
with the search terms ‘opt-out’ and ‘emergency care’ or ‘trauma’. 
Articles were reviewed to determine their relevance to the following 
aspects of opt-out testing in the ED: patient acceptance, patient 
satisfaction, provider satisfaction, the overall uptake and challenges 
faced, and ethical issues.
Results
HIV testing in LMICs
In Botswana opt-out testing has been successfully adopted with high 
community uptake.[11] SA legal minds suggest a change in the view 
about counselling prior to testing, asserting that the special protocols 
and procedures for HIV testing and diagnosis reinforced ‘the internal 
dimension of stigma’ that had prevented many from taking a test.[12] 
Numerous studies show HIV prevalence in EDs is high. In Kenya 
an implementation pilot study reported that 97% of patients offered 
testing assented, with a 22% HIV-positive rate. Of the positive group, 
82% were compliant with treatment at subsequent follow-up.[13] In 
Uganda, a HIV prevalence of 50% was demonstrated by testing every 
sixth ED patient.[14] Of these patients 83% were previously unaware 
of their HIV status.[15] In Guyana, a 30% HIV prevalence in ED-tested 
patients was found.[16] 
India has the second largest cohort of HIV disease after Africa. 
A study from Northern India demonstrated that opt-out testing 
was feasible and necessary with a 2% HIV-positive rate. It included 
neurosurgical emergency cases, as ‘these pose higher risk to the 
surgeon’.[17]
Opt-out testing acceptance
In Uganda 95% accepted testing in the ED when offered opt-out 
testing by a provider.[14] Of 233 patients who were offered HIV testing, 
99% supported HIV testing in the ED and 86% believed testing would 
improve linkage to care.[15] Using a closed-question survey with a 
convenience sample of patients in the ED,[16] out of 343 patients 
interviewed, 75% were amenable to opt-out testing if offered in the 
ED. Patients >50 years old, females, and those who had not been 
previously tested were more likely to refuse hypothetical HIV testing. 
The two most common reasons for declining were, recent HIV test 
(85%, 95% CI 74.0 - 91.4%) and not considered a risk for HIV/AIDS 
(83%, 95% CI 73.0 - 90.4%). In this study >30% of patients had never 
been tested for HIV, with 40% reporting receiving all healthcare in the 
ED. Fear, stigma and embarrassment (19%, 11.7 - 30.4%), rejection 
(30%, 20.3 - 41.5%), and being afraid (21%, 12.7 - 31.8%) were also 
reasons for declining hypothetical HIV-based testing. 
Acceptance of the opt-out concept by potential patients varied 
worldwide from 53% to 97%[13,16,18-22] with refusal rates in an American 
ED decreasing from 47% to less than 26%, as people became accus-
tomed to it over time.[19] A randomised controlled trial (RCT) of 
48 000 ED patients in the USA randomised patients to one of the 
three arms (opt-in, active choice, and opt-out): 38%, 51%, and 66%, 
respectively, supported opt-out consent as being superior.[23] A 2011 
study utilising comparative time-sequencing found a 78% uptake of 
HIV testing in the opt-out group compared with 63% in the traditional 
counsel-and-test method.[20] Rates of acceptance approaching 86% 
were found in the Deep South of the USA, where the HIV prevalence 
and TB rates are the highest.[21] The positive feasibility study of the 
opt-out system led to calls for its expansion to all EDs in the USA.[22] 
Three groups of patients refused testing: 
• those previously tested positive 
• previously tested negative 
• those who did not consider themselves at risk.[16,19]
Conversely, a study in Singapore was unfavourable for opt-out tes-
ting, with only 21% permitting testing.[24] The refusals were largely 
from older patients and from Chinese citizens who mentioned fear 
of receiving a positive result as a reason, which may reflect a cultural 
variance of the acceptability of opt-out testing. 
In California patient perceptions and satisfaction were assessed 
during opt-in and opt-out periods.[25] No difference was found in the 
attitudes and feelings toward either type of testing. However, the 
opt-out method had a higher overall uptake. Patients did not report 
feeling coerced to test and maintained their autonomy in deciding 
whether to be tested, including the opt-out system. Preserving the 
patient’s perception of autonomy with opt-out HIV screening is 
important because this has been cited as a major concern with the 
concept in the past.
Assessing patient perceptions of opt-out testing at a major trauma 
centre in Alabama,[26] patients overwhelmingly reported support 
for testing and identified the access to increased knowledge (41%), 
prevention of further transmission (12.5%), test availability and 
convenience (11.8%), along with potential access to treatment (4.9%) 
among the advantages of the opt-out approach. Fear and denial of HIV 
status as a reason to avoid testing was reported by <5% of patients.
Of 34 patients, from varied backgrounds, polled at a public 
teaching hospital in New York about their understanding of, beliefs 
about and reaction to opt-out testing in the ED,[27] some lack of 
understanding of the option to opt out was found, but they were 
generally in favour, citing the potential health benefits as the main 
reason to support the opt-out process. The main confusion was that 
participants incorrectly assumed that they would face mandatory 
testing, rather than having the option to refuse, especially if not of 
decision-making capability.
Opt-out testing and HIV prevalence
In Denver, Colorado,[28] an HIV prevalence of 2% was found when 
de-identified discarded blood specimens tested anonymously in a 
cohort of 600 patients who had opted out (declined testing), com-
pared with a 0.75% prevalence of HIV infection in those who opted 
in (accepted testing). The relative risk of positive tests was high 
(2.74) in this patient cohort, compared with those who accepted 
testing. A similar result was found in 2015 in a concordant identity-
unlinked study in parallel to an opt-in rapid oral-fluid HIV screening 
programme in 3 207 patients. They found an HIV incidence of 1.3% 
in those who declined testing compared with 0.4% in those who 
accepted testing (p=0.077).[29] 
Cost-effectiveness
In a public-funded health system the cost-effectiveness and therefore 
the longitudinal feasibility is an important consideration. Only one 
study in Denver, Colorado in the USA, a relatively low-incidence 
community, has reviewed this aspect of the opt-out programme. Their 
opt-out programme was more expensive, yet did almost triple the 
yield of new HIV diagnoses, with a much higher overall testing rate 
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(25% v. 0.8% of those given the options to either opt-out or opt-in, 
respectively). The costs were mainly those of test kits (USD 9.50 each, 
amounting to over USD 70 000), start-up, computer services and staff 
costs (USD 60 000 v. USD 30 000) and sundries used (due to the larger 
number of tests, not an actual increase in unit costs).[30]
The potential cost-savings and knock-on transmission reduction, 
due to early diagnosis, are difficult to determine. This aspect of social 
justice is also an important consideration. Addressing this, a study 
demonstrated that >40% of known HIV cases in care at the time 
could be identified and that early referral led to better care linkage, 
with over 90% care inclusion in their cohort.[31] They found that it is 
cost effective as it costs less than USD 10 000 per disease-adjusted 
life year (DALY) saved. Any saving of less than USD 50 000 per DALY 
is considered a cost-effective intervention.[31] This is also likely to be 
positively influenced by the modern ‘fourth-generation’ rapid test 
kits currently available for use in the ED, where almost 25% of newly 
diagnosed cases would have been missed with older test kits.[32]
Discussion
The SA National HIV counselling and testing (HCT) guidelines 
mandate that provider-initiated HIV counselling and testing (PICT) 
be offered to all persons attending clinical services in the public and 
private sectors. However, PICT is time consuming and requires trained 
HIV counsellors to initiate testing. In busy high-volume EDs, where 
patients often present in the evenings and weekends, this strategy 
has been difficult to adopt by many healthcare centres. Therefore HIV 
testing is not routinely available in many SA EDs. 
Given the high burden of disease in SA, the CDC recommended 
opt-out criteria potentially includes all SA health districts.[4] Opt-
out testing is less resource intensive, as it does not require pre-
counselling and there is an opportunity to destigmatise the disease. 
The potential for earlier diagnosis, during ED care, may allow for more 
accurate diagnosis, especially for infective processes. These aspects 
will address the concern over lack of autonomy and the potential 
reduced respect for persons.
From a clinician safety perspective, clinicians benefit by knowing 
the status of their individual patients. This can reduce stress and inform 
management should a potential on-duty injury occur, such as a blood 
splash or needle-stick injury. It may also reduce the need for post-expo-
sure prophylaxis with its attendant side-effects, which is pertinent given 
the close association of HIV status and other risk-taking behaviours resul-
ting in admission to EDs and trauma units.[33] This safety concern was 
raised in 1983 (when HIV prevalence was identified as 6% in a US ED) and 
advocated for the adoption of universal precautions during all patient 
interventions.[34] This addresses the ethical aspects of social justice.
Given the link between lower socioeconomic status, major trauma 
and alcohol-related pathology, expanding this policy to include the 
major trauma patient and the critically ill who are under sedation 
and on mechanical ventilation will benefit patient care (principle 
of beneficence), as the clinician will know the status and avoid 
unnecessary delays in seeking atypical organisms and opportunistic 
infections (principle of non-maleficence). Providing antiretroviral 
therapy to critically ill patients who may already be on treatment, 
but whose status is unknown due to reduced level of consciousness 
at their time of admission is also important. ED-based testing is also 
likely to capture high-risk patients, who are unlikely to access primary 
care where HIV testing is offered.
Although this is a novel approach in SA policies, it makes medical 
sense given the high rates of HIV/AIDS and trauma and the uprated 
CD4 levels for initiating HAART. Most research sites excluded sexual 
assault victims, prisoners and those needing resuscitation, while in 
SA these are the very persons at risk for a missed early diagnosis of 
HIV. With the recent announcement that HAART will be available to 
people with CD4 <500 cells/mm3 rather than <350 cells/mm3 and the 
option of lifelong therapy in all pregnant women,[35] early diagnosis 
and treatment becomes even more important from a clinical, ethical 
and public health perspective.
From the ethical perspective a recent robust qualitative study 
used structured interviews with stratified participants, to poll the 
views of 25 persons involved in HIV advocacy, care, policy, and 
research within the USA about the opt-out implementation and 
its controversial aspects.[36] Opt-out testing improved the process 
and access to testing, had long-run societal benefits, and allowed 
individuals earlier linkage to care. Challenges and potential risks 
or harms included: concerns around informed consent, quality of 
follow-up after diagnosis, and rushing through the opt-out process 
to secure testing. From an ethical perspective the respondents 
all agreed it would enable destigmatising the disease. However, 
most participants agreed with removing the need for a signed 
consent form as this removed the need to declare risk-taking 
behaviour before testing. An identified risk was a loss of ‘teachable 
moments’ often identified during pre-counselling under the opt-in 
system. However the destigmatisation of the disease was of higher 
significance. They were also hopeful that the ultimate good intent 
of the recommendations may be developed into a framework 
for implementation and that helpful dialogues on improving the 
practicalities of HIV testing would result. 
Long-term cost efficacy has been addressed in a systematic review 
examining the cost saving of surgical access in LMICs. Trauma care 
was as cost-effective as voluntary counselling and testing, but far 
more cost-effective than the treatment of HIV/AIDS and TB.[37] While 
the cost of treating trauma makes sense, it follows to add opt-out 
HIV testing where that care is provided to further enhance holistic 
diagnosis and treatment.
However, even with the adoption of an opt-out testing strategy 
many patients are still likely to reject HIV testing.[23] To maximise 
test acceptance and subsequent new HIV diagnoses, evidence 
must be used for decisions about the best way to conduct testing 
procedures.[38] The SA government is therefore urged to move 
toward an opt-out testing system in preference to the current opt-
in system.
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